# Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/bevacizumab-avastin-in-cancer-treatment-a-review-of-15-years-of-clinical/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Josep Garcia,Herbert I. Hurwitz,Alan B. Sandler,David Miles,Robert L. Coleman,Regula Deurloo,Olivier Chinot |
| Citations | 1,153 |
| DOI | 10.1016/j.ctrv.2020.102017 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3013347515 |
| PMID | 32335505 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Robert L. Coleman](https://scholariq.org/researchers/robert-l-coleman/)

## Paper primary topic

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

## Paper topics

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.